SCHEMBL25003144

SCHEMBL25003144

NNC(=O)c1nccc(-c2ccc(OC3CCCC3)cc2)n1

nearest known ligand 0.51

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ KMO O15229 6/20 0.51
▸ FDPS P14324 3/20 0.46
▸ MEN1 O00255 2/20 0.43
▸ KMT2A Q03164 2/20 0.43
▸ NPC1 O15118 1/20 0.42
▸ ALDH1A1 P00352 1/20 0.42
▸ LMNA P02545 1/20 0.42
▸ RAB9A P51151 1/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ FFAR4 Q5NUL3 2/20 0.42
▸ PARP10 Q53GL7 1/20 0.41
▸ GRM5 P41594 2/20 0.40
▸ HIF1A Q16665 1/20 0.39
▸ TYK2 P29597 1/20 0.39
▸ JAK3 P52333 1/20 0.39
▸ ABL1 P00519 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25003563 0.84 KMO (0.52) KMOFDPSMEN1KMT2ANPC1
SCHEMBL25003802 0.81 FDPS (0.48) FDPSKMT2ANPC1ALDH1A1LMNA
SCHEMBL25003146 0.80 ALDH1A1 (0.54) KMOMEN1KMT2ANPC1ALDH1A1
SCHEMBL25003151 0.79 ALDH1A1 (0.57) KMOMEN1KMT2ANPC1ALDH1A1
SCHEMBL25003827 0.79 FDPS (0.46) FDPSMEN1KMT2ANPC1ALDH1A1
SCHEMBL25003161 0.78 FDPS (0.58) FDPSNPC1ALDH1A1LMNARAB9A
SCHEMBL25003143 0.77 MEN1 (0.48) KMOMEN1KMT2ANPC1ALDH1A1
SCHEMBL25003132 0.77 CYP2D6 (0.50) MEN1KMT2ANPC1ALDH1A1LMNA
SCHEMBL25003145 0.77 KMT2A (0.48) KMOMEN1KMT2ASMN1; SMN2ABL1
SCHEMBL30862201 0.76 ALDH1A1 (0.50) KMOMEN1KMT2AALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023010192-A1 N-ACYLHYDRAZONE COMPOUNDS CAPABLE OF INHIBITING NAV1.7 AND/OR NAV1.8, PROCESSES FOR THE PREPARATION THEREOF, COMPOSITIONS, USES, METHODS FOR TREATMENT USING SAME, AND KITS EUROFARMA LABORATÓRIOS S.A. (BR) 2023-02-09 — — WO disclosed
Send feedback